Neurostimulation Devices Market To Reach USD 13.70 Billion by 2027 Growing at a CAGR of 12.6% | Emergen Research

The rising geriatric population, coupled with the increasing prevalence of neurological diseases, is driving the demand for the neurostimulation devices market.

Vancouver, British Columbia, Dec. 02, 2020 (GLOBE NEWSWIRE) -- The Global Neurostimulation Devices Market will be worth USD 13.70 Billion by 2027, according to the latest analysis by Emergen Research. The growth of this market can be attributed to the growing incidences of health disorders due to unhealthy lifestyle habits and is expected to drive the growth of the neurostimulation devices market. Recent developments in neurotechnology are resulting in the rapid utilization of neurostimulation therapies in treating patients suffering from neurological disorders. The economic development and increasing Healthcare Budgetary Allocation in developing countries is expected to drive the growth of the neurostimulation devices market.

The high cost of neurostimulation devices and the presence of alternative therapeutic procedures is likely to hamper the demand for neurostimulation devices over the forecast period. Adverse effects and risks pertaining to the use of neurostimulation devices, such as allergic reactions or prickling of skin, might restrict the utilization of neurostimulation devices. Moreover, stringent government regulations on device approval might act as a barrier to the growth of the market.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@

Key Highlights From The Report

  • In September 2019, the U.S. Food and Drug Administration (FDA) approved Abbott’s Proclaim XR™ recharge free neurostimulation platform for people living with chronic pain. The approval helped Abbott to secure a higher market share and increase its neurostimulation devices product portfolio.
  •  Deep brain stimulators held the second largest market share of 19.8% in 2019. The rising incidence of neurological disorders among the rising global geriatric population is expected to boost the demand for Deep brain stimulators.
  • Urinary and fecal Incontinence is expected to register steady growth over the forecast period. Increasing utilization of the sacral nerve stimulators for the treatment of Urinary and fecal Incontinence is expected to drive the growth of the neurostimulation devices market.   
  • North America accounted for the largest market share of the Neurostimulation Devices market in 2019 due to the improved healthcare system and government funding for the research and development of neurostimulation devices.
  • Key participants include Boston Scientific Corporation, St. Jude Medical, Medtronic, Neuronetics, Inc., Codman & Shurtleff, Inc., Nevro Corporation, Intrapace, Abbott Laboratories, LivaNova PLC, and Bayer AG, among others.

ORDER NOW (Customized Report Delivered as per Your Specific Requirement)@

Emergen Research has segmented the global Neurostimulation Devices Market on the basis of product, application, and region:

  • Product Outlook (Revenue, USD Billion; 2017-2027)
    • Sacral Nerve stimulator
    • Spinal Cord Stimulator
    • Vagus Nerve Stimulator
    • Gastric Electric Stimulators
    • Deep Brain Stimulators
  • Application Outlook (Revenue, USD Billion; 2017-2027)
    • Epilepsy
    • Depression
    • Dystonia
    • Gastroparesis
    • Pain management
    • Urinary and Fecal Incontinence
    • Essential Tremor
    • Parkinson’s Disease
    • Others

To identify the key trends in the industry and read full summary click on the link:

  • Regional Outlook (Revenue, USD Billion; 2017-2027)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Take a Look at our Related Reports:

In Silico Drug Discovery Market By Workflow (Discovery, Preclinical Tests, Clinical Trials), By Product (Consultancy as a Service, Software as a Service), By Type of Large Molecule, By End User (Contract Research Organizations, Pharmaceutical Industry), and By Region, Forecasts to 2027

Human Microbiome Modulators Market By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Neurological Disorders, Cancers, Dermatological, Gastrointestinal, Metabolic), By Region Forecasts to 2027

Intelligent Drug Discovery Market By Offering (Software, Services), By Technology (Machine Learning, Other Technologies), By Application (Neurodegenerative Diseases, Metabolic Diseases, Immuno-Oncology), By End User (Contract Research Organizations), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkdIn | Twitter | Blogs

Read Full Press Release@


Contact Data